| Literature DB >> 36234674 |
Sofia L Ramírez-Rosas1, Enrique Delgado-Alvarado2, Luis O Sanchez-Vargas3, Agustin L Herrera-May2,4, Mariana G Peña-Juarez5, J Amir Gonzalez-Calderon6.
Abstract
In previous work, the isolated polyphenolic compound (PPC) quercetin was used as a reducing agent in the formation of silver nanoparticles (AgNPs), testing two types of quercetin. This PPC is a bioactive molecule that provides the electrons for the reduction of silver ions to zerovalent silver. The results demonstrated that quercetin in dietary supplement presentation was better than reagent grade quercetin for the synthesis of AgNPs, and the difference between them was that the dietary supplement had microcrystalline cellulose (CM) in its formulation. Therefore, this dietary anti-caking agent was added to the reagent-grade quercetin to validate this previously found improvement. AgNPs were obtained at neutral pH by a green route using quercetin as a reducing agent and microcrystalline cellulose and maltodextrin as stabilizing agents. In addition, different ratios were evaluated to find the optimum ratio. Ultraviolet-Visible spectroscopy (UV-VIS), Atomic Force Microscope (AFM), Z-potential, Dynamic Light Scattering (DLS) and X-ray Powder Diffraction (XRD) were used for characterization. The antibacterial activity of the S. aureus and E. coli agent was tested by the disk diffusion and microdilution method. According to the results, this green synthesis needs the use of food stabilizer when working at pH 7 to maintain AgNPs in the long term. The ideal ratio of reducing the agent:stabilizing agent was 1:2, since with this system stable AgNPs are obtained for 2 months and with improved antimicrobial activity, validating this method was ecologically and economically viable.Entities:
Keywords: AgNPs; X-ray Diffraction (XRD); environmentally protective; nanostructure
Year: 2022 PMID: 36234674 PMCID: PMC9565511 DOI: 10.3390/nano12193545
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Preparation of AgNPs at different ratios of stabilizing agent.
| AgNPs | AgNO3 | Quercetin | Stabilizing Agent |
|---|---|---|---|
| (g) | (g) | (g) | |
| QR (1:0) | 0.0085 | 0.003 | 0 |
|
| |||
| QR:CM (1:0.5) | 0.0085 | 0.003 | 0.0015 |
| QR:CM (1:1) | 0.0085 | 0.003 | 0.003 |
| QR:CM (1:2) | 0.0085 | 0.003 | 0.006 |
| QR:CM (1:3) | 0.0085 | 0.003 | 0.009 |
| QR:CM (1:4) | 0.0085 | 0.003 | 0.012 |
|
| |||
| QR:MD (1:0.5) | 0.0085 | 0.003 | 0.0015 |
| QR:MD (1:1) | 0.0085 | 0.003 | 0.003 |
| QR:MD (1:2) | 0.0085 | 0.003 | 0.006 |
| QR:MD (1:3) | 0.0085 | 0.003 | 0.009 |
| QR:MD (1:4) | 0.0085 | 0.003 | 0.012 |
Figure 1UV-VIS absorption spectra and color change for each AgNPs system at different ratios of quercetin and stabilizing agent: microcrystalline cellulose and maltodextrin for different times.
Antibacterial activity by disc diffusion method of all AgNPs systems.
| AgNPs | Mean Inhibition Zone (mm) | |||
|---|---|---|---|---|
|
|
| |||
| Day 1 | Day 60 | Day 1 | Day 60 | |
| QR (1:0) | 10.07 ±0.77 | 9.87 ±0.73 | 7.33 ±0.51 | 7.14 ±0.38 |
| QR:CM (1:0.5) | 9.35 ±0.54 | 8.95 ±0.73 | 7.02 ±0.52 | 6.62 ±0.18 |
| QR:CM (1:1) | 9.19 ±0.50 | 9.89 ±0.45 | 7.09 ±0.36 | 7.24 ±0.29 |
| QR:CM (1:2) | 10.16 ±0.74 | 11.37 ±0.44 | 7.89 ±0.62 | 8.54 ±0.45 |
| QR:CM (1:3) | 9.37 ±0.78 | 10.82 ±0.22 | 7.15 ±0.32 | 7.42 ±0.26 |
| QR:CM (1:4) | 10.18 ±0.50 | 9.89 ±0.63 | 7.30 ±0.35 | 7.25 ±0.16 |
| QR:MD (1:0.5) | - | - | - | - |
| QR:MD (1:1) | 9.55 ±0.63 | 10.17 ±0.78 | 7.48 ±0.69 | 7.68 ±0.52 |
| QR:MD (1:2) | 10.11 ±0.38 | 11.23 ±085 | 7.90 ±0.30 | 8.18 ±0.25 |
| QR:MD (1:3) | 9.97 ±0.81 | 10.10 ±0.87 | 7.01 ±0.22 | 7.87 ±0.36 |
| QR:MD (1:4) | - | - | - | - |
| Positive control (AMC) | 15.28 ±0.29 | 15.34 ±0.18 | 10.43 ±0.40 | 10.30 ±0.14 |
AFM images, hydrodynamic diameter, PdI, and Z potential for the best AgNPs systems at different times.
| System | AFM | Hydrodynamic | Polydispersity | Z-Potential | ||||
|---|---|---|---|---|---|---|---|---|
| Day 1 | Day 60 | Day 1 | Day 60 | Day 1 | Day 60 | Day 1 | Day 60 | |
| QR |
|
| 79.1 ±4.4 | 14741.5 ±370.1 | 0.18 ±0.04 | 0.47 ±0.05 | −0.08 ±6.3 | −13.3 ±4.8 |
| QR:CM (1:2) |
|
| 56.2 ±1.1 | 86.6 ±3.4 | 0.16 ±0.02 | 0.18 ±0.03 | −22.0 ±3.2 | −34.6 ±4.3 |
| QR:MD (1:2) |
|
| 77.7 ±3.9 | 321.6 ±16.0 | 0.17 ±0.02 | 0.20 ±0.04 | −14.8 ±4.9 | −22.0 ±5.5 |
Figure 2XRD patterns for the best AgNPs systems at different times: (a) Day 1 and (b) Day 60.
MIC and MBC for the best AgNPs systems.
| System |
|
| ||
|---|---|---|---|---|
| MIC | MBC | MIC | MBC | |
| QR:CM (1:2) | 62.5 µg/mL | 250 µg/mL | 125 µg/mL | 500 µg/mL |
| QR:MD (1:2) | 125 µg/mL | 500 µg/mL | 250 µg/mL | 1 mg/mL |